TTK HEALTHCARE
|
TTK HEALTHCARE Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 44.47 | 31.61 | 13.10 | 26.03 | 8.72 |
| CEPS(Rs) | 53.71 | 40.67 | 22.01 | 35.24 | 18.89 |
| DPS(Rs) | 10.00 | 10.00 | 10.00 | 6.00 | 3.00 |
| Book NAV/Share(Rs) | 705.23 | 671.59 | 230.16 | 205.40 | 173.09 |
| Tax Rate(%) | 25.30 | 27.53 | 25.47 | -62.60 | 36.58 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 4.72 | 4.17 | 3.64 | 4.06 | 4.38 |
| EBIT Margin(%) | 10.98 | 8.90 | 4.69 | 5.11 | 3.51 |
| Pre Tax Margin(%) | 10.63 | 8.20 | 4.14 | 4.75 | 3.01 |
| PAT Margin (%) | 7.94 | 5.94 | 3.09 | 7.73 | 1.91 |
| Cash Profit Margin (%) | 9.59 | 7.65 | 5.19 | 10.46 | 4.13 |
| Performance Ratios | |||||
| ROA(%) | 5.32 | 5.20 | 3.56 | 8.04 | 2.94 |
| ROE(%) | 6.46 | 7.01 | 6.02 | 13.76 | 5.01 |
| ROCE(%) | 8.72 | 10.13 | 8.59 | 8.38 | 8.28 |
| Asset Turnover(x) | 0.67 | 0.88 | 1.15 | 1.04 | 1.54 |
| Sales/Fixed Asset(x) | 4.63 | 4.57 | 3.70 | 3.10 | 4.41 |
| Working Capital/Sales(x) | 0.90 | 0.88 | 2.66 | 2.55 | 5.10 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.22 | 0.22 | 0.27 | 0.32 | 0.23 |
| Receivable days | 41.18 | 35.37 | 34.52 | 52.35 | 44.37 |
| Inventory Days | 41.87 | 39.69 | 45.45 | 54.42 | 35.88 |
| Payable days | 114.99 | 112.47 | 130.35 | 160.52 | 111.76 |
| Valuation Parameters | |||||
| PER(x) | 33.35 | 32.71 | 63.29 | 19.00 | 37.50 |
| PCE(x) | 27.61 | 25.42 | 37.68 | 14.03 | 17.31 |
| Price/Book(x) | 2.10 | 1.54 | 3.60 | 2.41 | 1.89 |
| Yield(%) | 0.67 | 0.97 | 1.21 | 1.21 | 0.92 |
| EV/Net Sales(x) | 1.78 | 0.88 | 1.53 | 1.03 | 0.55 |
| EV/Core EBITDA(x) | 13.43 | 8.03 | 24.06 | 16.71 | 9.66 |
| EV/EBIT(x) | 15.45 | 9.56 | 32.71 | 20.09 | 15.78 |
| EV/CE(x) | 1.32 | 0.66 | 1.67 | 1.00 | 0.84 |
| M Cap / Sales | 2.78 | 2.01 | 1.96 | 1.47 | 0.72 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 3.82 | 21.01 | 25.88 | -26.28 | 2.85 |
| Core EBITDA Growth(%) | 25.42 | 108.76 | 30.47 | -21.08 | -35.31 |
| EBIT Growth(%) | 29.91 | 138.20 | 15.38 | 7.22 | -46.78 |
| PAT Growth(%) | 40.69 | 141.32 | -49.68 | 198.57 | -49.46 |
| EPS Growth(%) | 40.69 | 141.31 | -49.68 | 198.57 | -49.46 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | 0.03 | 0.06 | 0.06 | 0.12 |
| Current Ratio(x) | 5.50 | 5.06 | 2.13 | 1.99 | 1.74 |
| Quick Ratio(x) | 5.01 | 4.66 | 1.74 | 1.62 | 1.32 |
| Interest Cover(x) | 31.53 | 12.76 | 8.67 | 14.22 | 6.94 |
| Total Debt/Mcap(x) | 0.01 | 0.02 | 0.02 | 0.03 | 0.06 |
Compare Financial Ratios of peers of TTK HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TTK HEALTHCARE | ₹1,994.7 Cr | -0.5% | -5.8% | 1.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,595.0 Cr | 2.6% | 4.5% | 49.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,089.0 Cr | 3.2% | -2.9% | 54.9% | Stock Analytics | |
| CIPLA | ₹124,175.0 Cr | 2.8% | 1.5% | 21.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,625.0 Cr | 1.1% | 12.1% | 18.7% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹99,672.5 Cr | 1.5% | -0.1% | 41.6% | Stock Analytics | |
TTK HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TTK HEALTHCARE | -0.5% |
-5.8% |
1.7% |
| SENSEX | 1.9% |
-0.4% |
10.4% |
You may also like the below Video Courses
